138 related articles for article (PubMed ID: 17914712)
1. Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trials.
Snapinn S; Jiang Q
Stat Med; 2008 Feb; 27(3):382-91. PubMed ID: 17914712
[TBL] [Abstract][Full Text] [Related]
2. Indirect comparisons in the comparative efficacy and non-inferiority settings.
Snapinn S; Jiang Q
Pharm Stat; 2011; 10(5):420-6. PubMed ID: 21956948
[TBL] [Abstract][Full Text] [Related]
3. Assessing non-inferiority: a combination approach.
Gao P; Ware JH
Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568
[TBL] [Abstract][Full Text] [Related]
4. [Methodological and statistical aspects of equivalence and non inferiority trials].
Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
[TBL] [Abstract][Full Text] [Related]
5. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
6. Current issues in non-inferiority trials.
Fleming TR
Stat Med; 2008 Feb; 27(3):317-32. PubMed ID: 17340597
[TBL] [Abstract][Full Text] [Related]
7. Controlling the type 1 error rate in non-inferiority trials.
Snapinn S; Jiang Q
Stat Med; 2008 Feb; 27(3):371-81. PubMed ID: 17914715
[TBL] [Abstract][Full Text] [Related]
8. Testing and estimation in flexible group sequential designs with adaptive treatment selection.
Posch M; Koenig F; Branson M; Brannath W; Dunger-Baldauf C; Bauer P
Stat Med; 2005 Dec; 24(24):3697-714. PubMed ID: 16320264
[TBL] [Abstract][Full Text] [Related]
9. Issues on the selection of non-inferiority margin in clinical trials.
Hou Y; Wu XY; Li K
Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756
[TBL] [Abstract][Full Text] [Related]
10. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
11. Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratio.
Siqueira AL; Whitehead A; Todd S
Stat Med; 2008 Feb; 27(3):353-70. PubMed ID: 17628041
[TBL] [Abstract][Full Text] [Related]
12. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
Sankoh AJ
Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
[TBL] [Abstract][Full Text] [Related]
13. [Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?].
Marubini E; Rebora P; Reina G
Ital Heart J Suppl; 2004 Sep; 5(9):712-9. PubMed ID: 15568609
[TBL] [Abstract][Full Text] [Related]
14. Some fundamental issues with non-inferiority testing in active controlled trials.
James Hung HM; Wang SJ; Tsong Y; Lawrence J; O'Neil RT
Stat Med; 2003 Jan; 22(2):213-25. PubMed ID: 12520558
[TBL] [Abstract][Full Text] [Related]
15. ['Non-inferiority' trials. Tips for the critical reader. Research methodology 3].
Soonawala D; Dekkers OM
Ned Tijdschr Geneeskd; 2012; 156(19):A4665. PubMed ID: 22571548
[TBL] [Abstract][Full Text] [Related]
16. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
17. Issues in the assessment of non-inferiority: perspectives drawn from case studies.
Burger HU; Beyer U; Abt M
Pharm Stat; 2011; 10(5):433-9. PubMed ID: 21932300
[TBL] [Abstract][Full Text] [Related]
18. Alternatives for discounting in the analysis of noninferiority trials.
Snapinn SM
J Biopharm Stat; 2004 May; 14(2):263-73. PubMed ID: 15206525
[TBL] [Abstract][Full Text] [Related]
19. A note on special articles on adaptive clinical trial designs.
Chow SC
J Biopharm Stat; 2010 Nov; 20(6):1088-9. PubMed ID: 21058103
[No Abstract] [Full Text] [Related]
20. A combined superiority and non-inferiority approach to multiple endpoints in clinical trials.
Bloch DA; Lai TL; Su Z; Tubert-Bitter P
Stat Med; 2007 Mar; 26(6):1193-207. PubMed ID: 16791905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
